A cancer gene therapy approach through translational control of a suicide gene

被引:22
作者
DeFatta, RJ
Chervenak, RP
De Benedetti, A
机构
[1] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71130 USA
[2] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA
[3] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, Shreveport, LA 71130 USA
关键词
translation initiation factor eIF4E; translational control; gene expression in cancer; herpes thymidine kinase;
D O I
10.1038/sj.cgt.7700469
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The translation initiation factor eIF4E is elevated in most solid tumors resulting in translation of mRN As that are normally repressed by their structured 5' untranslated region. We have introduced a translational repressor element in a vector (BK-UTK) designed to express herpes thymidine kinase(HTK). This and a control vector (BK-TK) were used to treat experimental tumors of a murine breast cancer line. Both vectors were equally effective in reducing subcutaneous tumors and lung metastases following ganciclovir administration. However, the BK-TK vector was found to be highly toxic, resulting in severe weight loss, degeneration of various organs, and early death of mice following systemic vector delivery, whereas the BK-UTK increased mean survival without toxicity.
引用
收藏
页码:505 / 512
页数:8
相关论文
共 20 条
  • [1] Translational control: the cancer connection
    Clemens, MJ
    Bommer, UA
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1999, 31 (01) : 1 - 23
  • [2] Crew JP, 2000, BRIT J CANCER, V82, P161
  • [3] Ultrastructural changes in peripheral blood neutrophils in a patient receiving ganciclovir for CMV pneumonitis following allogenic bone marrow transplantation
    Ghosh, K
    Muirhead, D
    Christie, B
    Hiwase, D
    [J]. BONE MARROW TRANSPLANTATION, 1999, 24 (04) : 429 - 431
  • [4] Goldfarb Ronald H., 1992, Current Opinion in Oncology, V4, P1130, DOI 10.1097/00001622-199212000-00019
  • [5] MULTIDRUG RESISTANCE IN HUMAN CANCER
    GOLDSTEIN, LJ
    PASTAN, I
    GOTTESMAN, MM
    [J]. CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1992, 12 (03) : 243 - 253
  • [6] Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer
    Hall, SJ
    Mutchnik, SE
    Yang, G
    Timme, TL
    Nasu, Y
    Bangma, CH
    Woo, SLC
    Shaker, M
    Thompson, TC
    [J]. CANCER GENE THERAPY, 1999, 6 (01) : 54 - 63
  • [7] HEPPNER GH, 1986, MECH CANC METASTASIS, P69
  • [9] THE PROTOONCOGENE TRANSLATION FACTOR EIF4E - A SURVEY OF ITS EXPRESSION IN BREAST CARCINOMAS
    KEREKATTE, V
    SMILEY, K
    HU, B
    SMITH, A
    GELDER, F
    DEBENEDETTI, A
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (01) : 27 - 31
  • [10] Kevil C, 1995, ONCOGENE, V11, P2339